QIBGX
Price
$23.20
Change
+$0.11 (+0.48%)
Updated
Aug 6 closing price
Net Assets
282.94M
RLBCX
Price
$36.81
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
253.12B
Interact to see
Advertisement

QIBGX vs RLBCX

Header iconQIBGX vs RLBCX Comparison
Open Charts QIBGX vs RLBCXBanner chart's image
Federated Hermes MDT Balanced IS
Price$23.20
Change+$0.11 (+0.48%)
VolumeN/A
Net Assets282.94M
American Funds American Balanced R3
Price$36.81
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets253.12B
QIBGX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QIBGX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QIBGX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. QIBGX (283M). RLBCX pays higher dividends than QIBGX: RLBCX (1.56) vs QIBGX (1.43). QIBGX was incepted earlier than RLBCX: QIBGX (23 years) vs RLBCX (23 years). QIBGX (1.12) is less costly to investors than RLBCX (0.89). QIBGX is a more actively managed with annual turnover of: 68.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than QIBGX: RLBCX (250) vs QIBGX (1000000). RLBCX annual gain was more profitable for investors over the last year : 10.44 vs. QIBGX (8.17). RLBCX return over 5 years is better than : 34.86 vs. QIBGX (22.90).
QIBGXRLBCXQIBGX / RLBCX
Total Expense Ratio1.090.89122%
Annual Report Gross Expense Ratio1.120.89126%
Fund Existence23 years23 years-
Gain YTD8.9718.418107%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets283M253B0%
Annual Yield % from dividends1.431.5692%
Returns for 1 year8.1710.4478%
Returns for 3 years23.2530.1777%
Returns for 5 years22.9034.8666%
Returns for 10 years54.6961.8488%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN148.3220.09
+15.67%
Stride
CFG46.93-0.37
-0.78%
Citizens Financial Group
CMPS4.36-0.12
-2.68%
COMPASS Pathways Plc
CNTB2.13-0.07
-3.18%
Connect Biopharma Holdings Limited
APRE1.64-0.15
-8.38%
Aprea Therapeutics